“showed a trend”

Results showed a trend in favor of HIG treatment, but the difference between the two groups was not statistically significant (30 vs. 44%; p = 0.13).

To this end, OS cells were shown to express several components of the WNT signaling pathway and the chemotactic response to exogenous WNT was increased in a mouse metastatic OS cell line compared to the parental cells with low metastatic potential, and increased WNT10B expression showed a trend (n = 44; P = 0.13) to shorter survival in patients [ 45 , 46 ].

Interestingly, spines with PSs spinules showed a trend toward higher rates of perforated PSDs versus spines projecting AdjS spinules (24.1% vs. 10.0%, p = 0.13, n = 58 and 48, for PSs vs.

In these cases, LFP duration increased from 232 ± 27.7 ms in control to 624 ± 150 ms ( p = 0.002) (i.e., 2.7-fold), whereas the LFP rate showed a trend to rise from 42.3 ± 7.2/min to 57.3 ± 15.6 events/min ( p = 0.13). 3.3.

Similarly, in Leone's VECTIBIL trial, the addition of panitumumab showed a trend towards enhanced overall survival (OS) advantage in ICC patients (15.1 months vs 11.8 months, p = 0.13) [ 23 ], although this result did not reach statistical significance.

Similarly, in the KRT population, low SBC levels showed a trend towards increased mortality risk ( P = .13).

Patients with elevated cfDNA (≥3.35 log 10 hGE/ml, as defined by a Cox regression model) showed a trend towards inferior PFS ( p = 0.13, HR = 3.1, 95% Cl=0.64–14.95) (Fig. 3E ).

NADH histological staining on quadriceps muscle ( Figure 4A ) showed a trend towards smaller cross- sectional area (CSA) in light stained fibers in vitamin D insufficient mice (LOW: 3,057.1 ± 708.3 versus STD: 4,046.7 ± 977.1 μm 2 p=0.13, n =4 and 5, respectively , Figure 4B ).

Importantly, higher relative proportion of resting mast cells in HCC showed a trend toward shorter survival of patients (p = 0.13, data not shown) Total Immune cell infiltration and its correlation with immune cell types The extent of immune cell infiltration into tumors has important prognostic value in HCC and other cancers 5 , 9 , 15 , 19 .

Although hospital stay showed a trend favouring light anaesthesia (MD = -0.81 days; 95% CI: -1.85 to 0.24; P = 0.13), this result was not statistically significant (I2 = 89%).

Similarly, KB showed a trend for attenuation of HDM exposure induced IL-13 levels (p = 0.13).

Comparing scans after treatment with escitalopram (n = 8) to placebo (n = 8) showed a trend ( p = 0.13) towards lower extrastriatal SERT BPND in the SSRI group (median SERT occupancy of 64.6%).

Picolinic acid addition showed a trend (p = 0.13) toward increased lifespan.

When combined with 1q21 + , t(11;14) showed a trend toward poorer PFS (median PFS: 36 vs. 65 months; p = 0.130).

Patients with AF showed a trend of increased wall motion abnormalities compared with those without AF (11.1% vs. 5.9%, p = 0.13, respectively), whereas patients without AF had a trend to more patent foramen ovale than those with AF (6.6% vs. 0%, p = 0.06, respectively).

The pooled results showed a trend favoring the HA group, but did not show any differences (MD 6.01; 95%CI −1.74 to 13.75; P = 0.13).

Although the high APOC2 expression group showed a trend toward lower survival compared to the low expression group, this difference was not statistically significant (log-rank test, p = 0.13) ( Figure 4 B).

None of the markers showed difference in PRs between M0 and M1 patients, though VIM showed a trend towards higher PRs in M1 (59.5%) than in M0 group (20.5%, p = 0.13, Supplementary Table 4A).

20 , 21 However, including all variables in the multivariate model without stepwise selection, 6MWD < 165 m was a significant predictor of death in the non-SSc group (HR = 2.03; 95% CI, 1.01-4.12; P = .05), and 6MWD ≥ 440 m showed a trend toward a protective effect in the SSc group (HR = 0.62; 95% CI, 0.33-1.15; P = .13).

On the other hand, the T-allele of rs780094 showed a trend of increased FPG in rs1799884 AA carriers (0.14 mmol/l per allele, P = 0.13) but decreased FPG (−0.05 mmol/l per allele) in GG carriers ( P = 0.0045).

The Cox regression model with TOCI and ANA as separate covariates indicated that TOCI decreased (HR 0.31-95% CI 0.13-0.73, p=0.007) and ANA showed a trend in decreasing the risk of mortality (HR 0.46-95% CI 0.17-1.26, p=0.130).

Further, both the stroke groups showed a trend of shorter compensatory steps than healthy older adults ( p = 0.13).

Patients <55 also showed a trend towards an increased risk of death with a HR of 1.49 (p=0.13).

After 72 h, SC treatment showed a trend toward improved stability compared with BA (–13.98%, −31.45% to 3.483% 95% CI, P = 0.13) and NP (–16.10%, −35.18 to 1.745 95% CI, P = 0.08) ( Fig. 1 E ).

controls, although MCI/MI showed a trend of increasing values for all three proteases (each p = 0.13).